3D-Printed Versus Laboratory-Fabricated Hyrax Expanders
Ildeu Andrade Jr. · with American Association of Orthodontics Foundation · NCT05743127
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 8–13 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 42
- US sites recruiting
- 2
- Study start
- February 15, 2023
- Record last updated
- March 20, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Maxillary expanders are orthodontic appliances that are commonly used to expand the upper jaw. The purpose of this study will be to compare the effects produced by two different maxillary expanders in children 8-13 years old. The first type of expander is made by hand in an orthodontic laboratory, and the second type of expander is designed on a computer and printed using 3D printers. Both expanders are already used in the MUSC Orthodontics Clinic. The purpose of this study is to see if the 3D printed expander is as effective as the traditional expander made by hand in the laboratory, with more comfort to the patient. Patients participating in the study will be randomly assigned to one of two groups: group A will be treated with a laboratory-made maxillary expander, and group B with a 3D-Printed maxillary expander. Information will be collected on the participants' standard clinical follow-up visits including photos, x-rays, and dental photo scans over the course of 6 months to see how the expander is working. In addition, as part of the research study, the participant will be asked to complete online questionnaires with assistance from parents or guardians about his/her quality of life and perception of possible pain and discomfort at different time points. The potential benefits of this study include the use of 3D technology to improve the quality of the orthodontic treatment, with more comfort to the patient.
Being studied: 3D-Printed Hyrax Expander; Conventional Laboratory Fabricated Hyrax Expander
Conditions: Maxillary Expansion
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Maxillary anterior and/or posterior transverse deficiency with or without crossbite
- Age of 8-13 years
- Children whose parents/guardians are willing to consent to the child participating in the study
- Children ages 12-13 who are willing to assent to participating in the study
- Children who are orthodontic patients at the Medical University of South Carolina Department of Orthodontics or University of Pittsburgh School of Dental Medicine
- Subjects and parents/guardians who have access to an electronic device with internet connection
Exclusion Criteria
- Patients with previous or ongoing orthodontic treatment
- Patients whose parents have a strong preference as to which expander is used
- Patients with a history of temporomandibular disorders
- Presence of congenitally missing teeth
- Traumatic loss of maxillary incisors
- Patients with craniofacial syndromes, or cleft lip and/or palate
Recruiting US locations
University of Pittsburgh - School of Dental Medicine
Pittsburgh, PA 15213
Site contact: Ildeu Andrade, DDS, MS, PhD · 412-648-3369 · ildeu.andrade@pitt.edu
Medical University of South Carolina
Charleston, SC 29425
Site contact: Ildeu Andrade, DDS, MS, PhD · 8437923366 · andradei@musc.edu
Study contacts (from the official record)
- Ildeu Andrade, DDS, MS, PhD · 843-792-3366 · ildeu.andrade@pitt.edu
Similar studies in Pennsylvania
All healthy volunteers studies in Pennsylvania →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC
Melissa Pugliano-Mauro
- Location
- Pittsburgh, PA
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Philadelphia, PA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Philadelphia, PA + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Novo Nordisk A/S
- Location
- Hershey, PA + 4 other US sites
- Eligibility basics
- Ages 18–64 · Men only